Evaluation and management of patients after implantable cardioverter-defibrillator shock

被引:21
|
作者
Gehi, Anil K.
Mehta, Davendra
Gomes, J. Anthony
机构
[1] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA
[2] CUNY Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA
来源
关键词
D O I
10.1001/jama.296.23.2839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context There has been a tremendous increase in the use of implantable cardioverter-defibrillators (ICDs) after several large clinical trials demonstrated their ability to effectively reduce mortality in selected populations of patients with cardiac disease. Thus, the nonelectrophysiologist will often encounter patients who have received an ICD shock. Objective To assess options for the evaluation and management of patients who have received an ICD shock. Evidence Acquisition Literature search using the PubMed and MEDLINE databases to identify articles published from January 1990 to September 2006, using the Medical Subject Headings defibrillators, implantable; defibrillators, implantable/ adverse effects; anti-arrhythmic agents; electric countershock; quality of life; tachycardia therapy; algorithm; ventricular tachycardia/diagnosis; and supraventricular tachycardia/ diagnosis. Case reports were excluded and articles were limited to those published in English. Scientific statements and guidelines from the American College of Cardiology, the American Heart Association, and the Heart Rhythm Society were also reviewed, as were the reference lists of retrieved articles, to identify any additional articles for inclusion. Evidence Synthesis There are multiple causes of both appropriate and inappropriate ICD shocks. Irrespective of appropriateness, receiving ICD shocks substantially impairs a patient's quality of life. A variety of techniques are available using ICD programming to reliably limit the occurrence of appropriate or inappropriate ICD shocks. Antiarrhythmic medications can also effectively reduce the occurrence of shocks. Conclusions Through the use of effective ICD programming and antiarrhythmic medications, the occurrence of ICD shocks can be reduced while maintaining the lifesaving ability of the ICD. A basic understanding of the range of available options is fundamental for evaluation and management of the patient who has received an ICD shock.
引用
收藏
页码:2839 / 2847
页数:9
相关论文
共 50 条
  • [1] How to respond to an implantable cardioverter-defibrillator shock
    Sears, SF
    Shea, JB
    Conti, JB
    CIRCULATION, 2005, 111 (23) : E380 - E382
  • [2] Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
    Nault, Michael A.
    McIntyre, William F.
    Simpson, Christopher S.
    Redfearn, Damian P.
    Abdollah, Hoshiar
    Brennan, F. James
    Baranchuk, Adrian
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2010, 15 (02) : 181 - 183
  • [3] Selecting patients for an Implantable cardioverter-defibrillator
    Mittal, Suneet
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (03) : 297 - 299
  • [4] The implantable cardioverter-defibrillator
    Raj, SR
    Sheldon, RS
    PROGRESS IN CARDIOVASCULAR DISEASES, 2001, 44 (03) : 169 - 194
  • [5] The implantable cardioverter-defibrillator
    Greene, HL
    CLINICAL CARDIOLOGY, 2000, 23 (05) : 315 - 326
  • [6] The implantable cardioverter-defibrillator
    Groh, WJ
    Foreman, LD
    Zipes, DP
    AMERICAN FAMILY PHYSICIAN, 1998, 57 (02) : 310 - 312
  • [7] Patients with Pacemaker or Implantable Cardioverter-Defibrillator
    Schulman, Peter M.
    Rozner, Marc A.
    Sera, Valerie
    Stecker, Eric C.
    MEDICAL CLINICS OF NORTH AMERICA, 2013, 97 (06) : 1051 - +
  • [8] Evaluation of Chest Pain after Implantable Cardioverter-Defibrillator Placement
    Gahremanpour, Amir
    Saeed, Mohammad
    Birnbaum, Yochai
    TEXAS HEART INSTITUTE JOURNAL, 2017, 44 (03) : 226 - 226
  • [9] Implantable Cardioverter-Defibrillator Shock after Stenting Across the Device Leads
    Mehra, Sanjay
    Chelu, Mihail Gabriel
    TEXAS HEART INSTITUTE JOURNAL, 2016, 43 (01): : 88 - 90
  • [10] SHOCK WITHOUT WIRES: A LOOK AT SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR COMPARED TO TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR FOR VENTRICULAR ARRHYTHMIAS
    Guice, K. C.
    Raja, J.
    Oberoi, M.
    Khouzam, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 493 - 493